Member Info for druml

Richard and the team are so incredibly easy going.

No big company stress.

All a out teamwork

Can someone ask at the AGM if the board are aware of any bid seller. Particularly an early institutional or VC investor.

Have a good day if attending .

Cake next year.

Adrian comment on perfect timing sounds like there is more news soon.

Dont expect rns first thing tomorrow.

US time.

They will need to evaluate and prepare statements,

So expect later in the week

Let sleeping dogs lie .

Back in autumn for any news

Enjoy the summer

This is an accurate assessment

Too much ramping

Wait until autumn or bail out now

Nothing is happening for months on the sp

Drifting until autumn.

Sell in may and go away was old saying.

Don't expect anything until autumn

Maybe someone else thinks nothing happening until autumn at least.

Great post showing the potential even before a buyout by big

pharma

The broker will have them placed in a day.

But if selling cheap and you need to sell i will buy them all.

This project has immense potential.

Roche will buy them out as the project progresses.

They already have good working relationships

Well done to the professional management team.

Fusion have a relationship with Roche for some time.

Fusion redesigned one of their key antibody drugs and extended the billion dollar drugs patent life.

Fusion cso on the patent.

They will sure be interested in optimal!!

Definitely appears a case of trading on inside information.

Hope this is investigated

Agreed

They are getting the science and project peer reviewed by world experts . This takes time. It will then be published is a l

Just did a Google search and find that the largest diagnosis company is Roche.

Now fusion have great history with Roche. They redesigned one of their top selling antibody drugs.

Extended the life of the billion dollar drug. Fusion cso even named on the patent I understand.

This relationship could be very big.

Anyone have more information or views

Very positive delivery by CEO. He really knows the business and market.

Things look very positive.

Peer review of the optimal will be a big endorsement. This will be done by top science names in world. You could not pay for this type of exposure.

Interesting that they are working with the world leading diagnosis companies on multiple projects.

They have done a great job.

Share price will follow.